AbiVax’s Partnering Prospects For MicroRNA-based Drug Boosted By Rheumatoid Arthritis Data
Phase IIa RA Results Build On Ulcerative Colitis Promise
• By Sten Stovall
AbiVax reported excellent Phase IIa Clinical Safety And Efficacy Results in RA With 50mg ABX464 • Source: Alamy 
